Organ Transplantation Market increasing demand with Industry Professionals

Posted by Vinit on January 13th, 2021

Organ transplantation is a medical procedure in which the organ is removed from one body and transferred to another body to replace the organ that is missing or damaged. One of the major aspects of organ transplantation is the approval of the patient or the patient’s family. Organ harvesting without prior permission is illegal and a serious crime.

As per Market Research Future (MRFR) analysis, the global organ transplantation market is expected to grow at 9.8% CAGR from 2017 to 2023 (forecast period).

Key Drivers

Some of the leading participants in the global organ transplantation market are Terumo Medical Corporation (US), Transonic (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis International AG (Switzerland), OrganOX Limited (UK), Bio Med Pvt. Ltd. (US), Astellas Pharma, Inc (Japan), Transplant Biomedical (UK), TransMedic, Inc. (US), Accord Healthcare GmbH (Spain), Preservation Solutions, Inc. (US), Sanofi (France), Pfizer, Inc. (US), Veloxis Pharmaceuticals A/S (Denmark), GlaxoSmithKline Plc. (UK)

Market Segmentation

The global market for organ transplantation has been segmented into type, product, type of transplant, treatment, and end-users.

Based on type, the global market for organ transplantation has been segmented into organs, heart, kidney, liver, lungs, and others.

Based on treatment, the global market for organ transplantation has been segmented into immunosuppressant, analgesic, and other. An immunosuppressant is further divided into calcineurin inhibitors, mTOR inhibitor, antiproliferative agents, steroids, and others. Calcineurin Inhibitors are sub-segmented into tacrolimus and cyclosporine. mTOR inhibitor is sub-segmented into sirolimus and everolimus.

Market Dynamics

The key driver of organ transplant demand is the rise in the prevalence of chronic diseases and organ failure. Increased incidence of kidney disease, over-consumption of alcohol, and insalubrious diets have led to the development of the organ transplantation market. Whereas the high costs of transplantation, the small number of donors, and the rising incidence of organ failure have restricted the industry’s growth.